Skip to Content
Skip to Content

Substance evaluation - CoRAP

Substance evaluation - CoRAP

For each substance, the table shows the evaluating Member State, the year of evaluation and a short description of the concern which led to it being placed on the list.

Community rolling action plan (CoRAP): The community rolling action plan covers three consecutive years and is updated mid of March every year. From this it follows that substances in the table below with the column ‘Year’ indicating a current or future year, are those that have been prioritised for evaluation, and are effectively on the current CoRAP.

Documents to do with substance evaluation are also available here. They include: documents justifying selection of the substances, decisions to request more information. Member States' conclusions and Member States' final evaluation reports are included for substances for which evaluation has been finalised.

 

Notes to the Substance Evaluation and CoRAP table
  • Where two Members States are indicated, this is a joint evaluation. The first Member State mentioned leads the Evaluation and is the responsible competent authority in the meaning of Article 45(2) of REACH.
  • The substance public name is used. In most of the cases it is the name as disseminated on the ECHA website.
  • When the EC Number is not available, the number assigned to substance by ECHA after the inquiry process is used.
  • When the substances are included in the CoRAP, they have not yet been evaluated and thus the concern is indicative and not exhaustive or conclusive.
  • Contact details of the evaluating Member States are provided for all the substance included.
  • Please note that the justification document explains the grounds of the initial concerns that triggered the inclusion of the substance in the CoRAP for further clarification under substance evaluation. The justification document is based on a preliminary screening of the substance and is without prejudice to the outcome of the substance evaluation.

Legend:

  • Suspected PBT/vPvB: Potentially Persistent, Bioaccumulative and Toxic/very Persistent and very Bioaccumulative.
  • CMR: generic term for known carcinogenic and/or mutagenic and/or reprotoxic properties (according to CLP harmonised or registrant self-classification or CLP Inventory). The concern can refer to C, M, R or a combination of those.
  • Suspected CMR: generic term for suspected carcinogenic and/or mutagenic and/or reprotoxic properties (not classified according to CLP harmonised or registrant self-classification). The concern can refer to (suspected) C, M, R or a combination of those.
  • Sensitiser: generic term for known sensitising properties (according to CLP harmonised or registrant self-classification or CLP Inventory).
  • Suspected sensitiser: generic term for suspected sensitising properties (not classified according to CLP harmonised or registrant self-classification).
  • RCR: Risk Characterisation Ratio
Last updated 13 December 2019. Database contains 375 unique substances/entries.
Filter the list
Initial grounds for concern:

 
200-817-4
74-87-3
2012
Italy
CMR
Potential endocrine disruptor
High RCR
Concluded
Details
200-262-8
56-23-5
2012
France
CMR
Exposure of workers
High (aggregated) tonnage
Conclusion under preparation
Details
287-477-0
85535-85-9
2012
Sweden
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
405-040-6
63500-71-0
2012
Spain
High RCR
Wide dispersive use
Concluded
Details
203-253-7
104-93-8
2012
Ireland
CMR
Consumer use
High RCR
Wide dispersive use
Concluded
Details
Bisphenol A; BPA
201-245-8
80-05-7
2012
Germany
Potential endocrine disruptor
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
205-743-6
149-57-5
2012
Spain
CMR
Consumer use
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
405-490-3
613-62-7
2012
Czech Republic
Other hazard based concern
High (aggregated) tonnage
Concluded
Details
201-289-8
80-54-6
2012
Sweden
CMR
Consumer use
Wide dispersive use
Ongoing
Details
204-278-6
118-79-6
2012
Norway
CMR
Suspected PBT/vPvB
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
203-868-0
111-42-2
2012
Germany
Suspected CMR
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
203-002-1
102-06-7
2012
France
CMR
High (aggregated) tonnage
High RCR
Ongoing
Details
284-366-9
84852-53-9
2012
Sweden
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
203-929-1
112-03-8
Italy
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Not started
Details
412-780-3
-
France
Suspected PBT/vPvB
Conclusion under preparation
Details
403-030-6
137398-54-0
Belgium
Suspected PBT/vPvB
Follow-up
Details
205-117-2
133-66-4
Italy
Suspected PBT/vPvB
Wide dispersive use
Not started
Details
234-126-4
10544-72-6
Latvia
Suspected Mutagenic
Suspected Reprotoxic
Exposure of workers
High RCR
Not started
Details
233-072-9
10028-22-5
Lithuania
Suspected Sensitiser
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Not started
Details
218-747-8
2224-33-1
Italy
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Not started
Details
245-366-4
22984-54-9
Italy
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Not started
Details
701-276-1
-
Estonia
CMR
Suspected PBT/vPvB
Sensitiser
Consumer use
High (aggregated) tonnage
Wide dispersive use
Not started
Details
200-076-7
51-03-6
Sweden
Potential endocrine disruptor
Suspected PBT/vPvB
Consumer use
Wide dispersive use
Not started
Details
700-604-0
947701-81-7
Finland
Suspected PBT/vPvB
Consumer use
Not started
Details
701-029-8
-
Estonia
CMR
Sensitiser
Consumer use
Wide dispersive use
Not started
Details
247-156-8
25640-78-2
Germany
Suspected PBT/vPvB
Wide dispersive use
Not started
Details

Export search results to:

Categories Display

Tagged as:

(click the tag to search for relevant content)


Route: .live1